Nestmedic S.A. (WSE:NST)

Poland · Delayed Price · Currency is PLN

0.6840

+0.0340 (5.23%)

Last updated: Oct 14, 2026, 3:50 PM CET

Market Cap	37.84M +13.3%
Revenue (ttm)	795.19K -25.3%
Net Income	-4.22M
EPS	-0.09
Shares Out	55.33M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	37,493
Open	0.6880
Previous Close	0.6500
Day's Range	0.6500 - 0.6880
52-Week Range	0.4900 - 0.8750
Beta	0.14
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 10, 2026

About Nestmedic

Nestmedic S.A., together with its subsidiaries, manufactures telemedicine solutions under the Pregnabit brand. The company offers Pregnabit Pro, a medical device for measuring fetal heart rate, uterine contraction activity, and signaling fetal movements; Pregnabit Cloud, a SaaS system for telemedical CTG devices; and Pregnabit system comprising the mobile CTG device and the medical telemonitoring center service. It sells its products through a distribution network and resellers worldwide. The company was incorporated in 2017 and is headquartere... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2017

Employees 3

Stock Exchange Warsaw Stock Exchange

Ticker Symbol NST

Full Company Profile

Financial Performance

In 2025, Nestmedic's revenue was 846,367, a decrease of -12.67% compared to the previous year's 969,196. Losses were -4.60 million, -14.52% less than in 2024.

Financial Statements